Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies.


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2020
Historique:
received: 11 11 2019
accepted: 04 03 2020
entrez: 10 3 2020
pubmed: 10 3 2020
medline: 27 7 2021
Statut: ppublish

Résumé

Human cell-based neural organoids are increasingly being used for investigations of neurotoxicity, and to study the pathophysiology of neurodegenerative diseases. Here, we present a fast and robust method to generate 3D cultured human dopaminergic neurons (LUHMES) for toxicity testing and long-term culture. Moreover, a plating step was introduced to allow generation of neurite networks with defined 2D orientation and several mm length, while all cell bodies (somata) remained in a 3D, dome-like structure. These cultures, named here 2.5D (for 2.5 dimensional), offer new approaches to quantify toxicant effects on organoids by standard technology and high throughput. For instance, the system reacted to the parkinsonian model toxicants MPP+, rotenone, MG-132 and the ferroptosis-inducer erastin. Moreover, stable incorporation of human stem cell-derived astrocytes or microglia was possible. Added astrocytes stabilized the post mitotic state of the LUHMES neurons and thereby allowed the formation of a stable micro-physiological system. We observed neuroprotection against the proteasome inhibitor MG-132 and the ferroptosis-inducer erastin by such glia. This exemplifies the crucial protective role of astrocytes in neurodegeneration. The modularity of the system was further employed to incorporate microglia together with astrocytes into the organoids. Such ratio-defined, three cell type-based organoids will allow new approaches to study human pathophysiology and toxicology of the nervous system.

Identifiants

pubmed: 32150624
doi: 10.14573/altex.1911111
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-428

Auteurs

Markus Brüll (M)

In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.

Anna-Sophie Spreng (AS)

In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany.

Simon Gutbier (S)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Dominik Loser (D)

NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.

Alice Krebs (A)

In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany.

Marvin Reich (M)

In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.
Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Udo Kraushaar (U)

NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.

Markus Britschgi (M)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Christoph Patsch (C)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Marcel Leist (M)

In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH